SCHEMBL1076282

SCHEMBL1076282

O=C(COc1ccccc1)C(NS(=O)(=O)c1ccc2ccccc2c1)C1CCNCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.49
MMP2 P08253 1/20 0.49
MMP3 P08254 1/20 0.49
MMP7 P09237 1/20 0.49
MMP9 P14780 1/20 0.49
MMP8 P22894 1/20 0.49
MMP13 P45452 1/20 0.49
ITGB3 P05106 7/20 0.47
ITGA2B P08514 7/20 0.47
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2C9 P11712 2/20 0.43
TSHR P16473 2/20 0.43
CYP2C19 P33261 2/20 0.43
SLC1A3 P43003 1/20 0.43
SLC1A2 P43004 1/20 0.43
SLC1A1 P43005 1/20 0.43
MAPT P10636 1/20 0.43
PKM P14618 1/20 0.43
KAT6A Q92794 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7255921 0.74 MMP3 (0.72) MMP1MMP2MMP3MMP7MMP9
SCHEMBL5370964 0.71 KMT2A (0.46) ITGB3ITGA2BMAPT
SCHEMBL5367918 0.71 ALDH1A1 (0.41) ITGB3ITGA2BMAPT
SCHEMBL1770350 0.68 MMP1 (0.67) MMP1MMP2MMP3MMP9MMP13
SCHEMBL932063 0.68 SMN1; SMN2 (0.59) F10
SCHEMBL933358 0.68 KMT2A (0.61) PKM
SCHEMBL932265 0.67 NPY5R (0.66)
Hydrochloric Acid SCHEMBL7352064 0.67 MMP2 (0.67) MMP1MMP2MMP3MMP7MMP9
Hydrochloric Acid SCHEMBL6793584 0.67 KMT2A (0.60) PKM
SCHEMBL10080945 0.67 BCHE (0.58) PKMF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2448581-B1 THERAPEUTIC COMPOSITIONS AND RELATED METHODS OF USE AGIOS PHARMACEUTICALS INC (US) 2016-12-07 EP disclosed
EP-2448581-A1 THERAPEUTIC COMPOSITIONS AND RELATED METHODS OF USE Agios Pharmaceuticals, Inc. (US) 2012-05-09 EP disclosed
WO-2011002816-A1 THERAPEUTIC COMPOSITIONS AND RELATED METHODS OF USE AGIOS PHARMACEUTICALS, INC. (US) 2011-01-06 WO disclosed